Pacific Biosciences of California

Pacific Biosciences of California

World Rank (Aug-2026)
13552
Market Cap (Aug-2026)
0.357 Billion USD
Market Cap (Mar-08-2026)
0.417 Billion USD
World Rank (Jan-05-2024)
4,994
Market Cap (Jan-05-2024)
2.470 Billion USD
World Rank (Jul-30-2023)
4,010
Market Cap (Jul-30-2023)
3.374 Billion USD
World Rank (Jan-07-2022)
4,147
Market Cap (Jan-07-2022)
3.697 Billion USD
World Rank (Jan-01-2021)
2,998
Market Cap (Jan-01-2021)
4.857 Billion USD
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
PACB
Employee Count
438
Employee Count as of Date
As on 2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
160 Million USD
Annual Operating Income in USD
-554 Million USD
Annual Net Income in USD
-546 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
784 Million USD
Total Liabilities in USD
779 Million USD
Total Equity in USD
5 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Medical Equipment / Instruments
Technology
Capital Goods
Company Website
PACIFIC BIOSCIENCES OF CALIFORNIA INC
Yahoo
Yahoo @ Nasdaq
Company Profile

Pacific Biosciences of California is a Biosciences provides sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges company. It offers the most comprehensive view of genomes, transcriptomes and epigenomes including the full spectrum of genetic variation by providing the longest average read lengths, highest consensus accuracy and most uniform coverage of any sequencing technology on the market today. The headquarters is in USA.

Facts About Company

The company annual revenue is 128 million USD as on 2022.

The company annual revenue is 130 million USD as on 2021.

Annual Results Summary

PACIFIC BIOSCIENCES OF CALIFORNIA- Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022128-304 (Loss)-314 (Loss)
Dec-2021130-178 (Loss)-181 (Loss)
Dec-202078-104 (Loss)29
Dec-201990-100 (Loss)-84 (Loss)
Dec-201878-100 (Loss)-102 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,767 Million USD.

Total Liabilities as on Dec-2022 was 1,204 Million USD.

Total Equity as on Dec-2022 was 562 Million USD

Founded Year
2004
IPO Year
2010
Stock Exchange
Nasdaq
Nasdaq Sector
Industrials
Nasdaq Industry
Biotechnology: Laboratory Analytical Instruments

Share